Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 11/20 | 0.52 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5488263 | 1.00 | SIGMAR1 (0.52) | SIGMAR1MAOAMAPTRXFP1MAOB | |
| SCHEMBL29118253 | 1.00 | SIGMAR1 (0.52) | SIGMAR1MAOAMAPTRXFP1MAOB | |
| SCHEMBL3791482 | 1.00 | SIGMAR1 (0.52) | SIGMAR1MAOAMAPTRXFP1MAOB | |
| SCHEMBL18979256 | 1.00 | SIGMAR1 (0.52) | SIGMAR1MAOAMAPTRXFP1MAOB | |
| SCHEMBL574732 | 1.00 | SIGMAR1 (0.52) | SIGMAR1MAOAMAPTRXFP1MAOB | |
| SCHEMBL1203381 | 0.98 | MAOA (0.52) | SIGMAR1MAOAMAPTRXFP1MAOB | |
| SCHEMBL1599233 | 0.91 | SIGMAR1 (0.48) | SIGMAR1MAOAMAOBL3MBTL1 | |
| SCHEMBL13707239 | 0.84 | SIGMAR1 (0.42) | SIGMAR1MAOAMAPTMAOBL3MBTL1 | |
| SCHEMBL16207822 | 0.83 | SIGMAR1 (0.50) | SIGMAR1MAOAMAPTRXFP1MAOB | |
| SCHEMBL10000437 | 0.83 | SIGMAR1 (0.50) | SIGMAR1MAOAMAPTRXFP1MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180219160-A1 | BENZOBIS(THIADIAZOLE) DERIVATIVE, INK COMPRISING THE SAME, AND ORGANIC ELECTRONIC DEVICE USING THE SAME | UBE INDUSTRIES, LTD. (JP) | 2018-08-02 | — | — | US | disclosed |
| EP-3181569-A1 | BENZOBIS(THIADIAZOLE) DERIVATIVE, INK CONTAINING SAME, AND ORGANIC ELECTRONIC DEVICE USING SAME | UBE Industries, Ltd. (JP) | 2017-06-21 | — | — | EP | disclosed |
| CN-106661057-A | Benzobis(thiadiazole) derivative, ink containing same, and organic electronic device using same | 宇部兴产株式会社 | 2017-05-10 | — | — | CN | disclosed |
| US-9303049-B2 | Nanodot and method for manufacturing the same | NATIONAL SUN YAT-SEN UNIVERSITY (TW) | 2016-04-05 | — | — | US | disclosed |
| US-20150073167-A1 | NANODOT AND METHOD FOR MANUFACTURING THE SAME | NATIONAL SUN YAT-SEN UNIVERSITY (TW) | 2015-03-12 | — | — | US | disclosed |
| US-8207529-B2 | Thin film transistor and flat panel display having the thin film transistor | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2012-06-26 | — | — | US | disclosed |
| US-20100308317-A1 | THIN FILM TRANSISTOR, METHOD OF MANUFACTURING THE SAME AND FLAT PANEL DISPLAY HAVING THE THIN FILM TRANSISTOR | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2010-12-09 | — | — | US | disclosed |
| US-7799597-B2 | Thin film transistor, method of manufacturing the same and flat panel display having the thin film transistor | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2010-09-21 | — | — | US | disclosed |
| US-7291747-B2 | Silicon compounds and process for preparation thereof | CHISSO CORPORATION (JP) | 2007-11-06 | — | — | US | disclosed |
| US-20070090362-A1 | Thin film transistor, method of manufacturing the same and flat panel display having the thin film transistor | SAMSUNG SDI CO., LTD. (KR) | 2007-04-26 | — | — | US | disclosed |
| US-20040143081-A1 | Novel silicon compounds and process for preparation thereof | JNC CORPORATION (JP) | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180219160-A1 | BENZOBIS(THIADIAZOLE) DERIVATIVE, INK COMPRISING THE SAME, AND ORGANIC ELECTRONIC DEVICE USING THE SAME | IKZF3, HELZ, TEC | SIGMAR1 3454/4885MAOA 815/4885MAPT 2949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.